Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
Clinical trial NCT00278421 · COMPLETED
Trial details
- NCT number
- NCT00278421
- Sponsor
- German High-Grade Non-Hodgkin's Lymphoma Study Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2018-08-01
- Enrollment
- 592
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.